Former divisional leader at Givaudan SA
- Competitive landscape focusing on strategic differences
- Second growth wave of naturals driven by functional ingredients developments
- Givaudan's (VTX: GIVN) strategic options in response to International Flavors & Fragrances (NYSE: IFF) and DuPont (NYSE: DD) Biosciences merger
- Input cost and pricing outlook
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.